CIBC World Market
ANAB icon

CIBC World Market’s AnaptysBio ANAB Stock Holding History

CIBC World Market’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Buy
+8,700
New +$527K ﹤0.01% 1170

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

CIBC World Market's ANAB Position: Q2 2026 in Review

CIBC World Market opened a new position in AnaptysBio (ANAB) in Q2 2026: 8,700 shares worth $587K. The stake represents ﹤0.01% of the portfolio and ranks #1170 among its holdings.

213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • CIBC World Market held 8,700 shares of AnaptysBio worth $587K as of Q2 2026.
  • AnaptysBio was a new CIBC World Market position in Q2 2026.
  • AnaptysBio made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1170 holding.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.